Outcomes of Selective Laser Trabeculoplasty as Initial Treatment for Glaucoma: A Retrospective Analysis from Enugu, Nigeria
Clinical Scorecard: Outcomes of Selective Laser Trabeculoplasty as Initial Treatment for Glaucoma: A Retrospective Analysis from Enugu, Nigeria
At a Glance
| Category | Detail |
|---|
| Condition | Glaucoma |
| Key Mechanisms | Selective Laser Trabeculoplasty (SLT) improves aqueous humor outflow, reducing intraocular pressure (IOP). |
| Target Population | Patients with open-angle glaucoma, including primary open-angle glaucoma (POAG), juvenile open-angle glaucoma (JOAG), or normal-tension glaucoma (NTG). |
| Care Setting | The Eye Specialists Hospital, Enugu, Nigeria. |
Key Highlights
- SLT shows IOP reduction efficacy ranging from 6.9% to 38.9%.
- Better IOP control and lower treatment costs observed with SLT compared to topical medications.
- Over 80%-90% of patients maintain IOP reduction of 20% one year post-treatment.
Guideline-Based Recommendations
Diagnosis
- Assess glaucoma severity using Humphrey mean deviation values.
Management
- Consider SLT as a first-line treatment for POAG and ocular hypertension.
Monitoring & Follow-up
- Evaluate IOP at 3, 6, 9, 12, 18, 24, and 36 months post-SLT.
Risks
- Initial cost, equipment availability, and training deficiencies may hinder SLT implementation.
Patient & Prescribing Data
Treatment-naïve patients with open-angle glaucoma.
SLT is gaining acceptance as a primary treatment option despite barriers.
Clinical Best Practices
- Use SLT for managing primary open-angle glaucoma in treatment-naïve patients.
- Ensure proper follow-up and monitoring of IOP post-SLT.
Related Resources & Content
